South America Dermatology OTC Medications Market Forecast to 2028 – COVID-19 Impact and Analysis – by Product Type (Tablets and Capsules, Gels, Creams and Ointments, and Others), Route of Administration (Topical and Oral), Indication (Dermatitis, Acne, Psoriasis, Skin Bleaching, Fungal Disease, Warts, and Others), and Distribution Channel (Online Distribution and Offline Distribution)      

BMIRE00025066 | Pages: 178 | Pharmaceuticals | Jun 2022 | Type: Regional | Status: Published

The SAM dermatology OTC medications market is expected to grow from US$ 935.31 million in 2021 to US$ 1,181.05 million by 2028; it is estimated to grow at a CAGR of 3.4% from 2021 to 2028.

One of the dermatology OTC medications market's most visible trends is the shift of manufacturers from prescription pharmaceuticals toward over-the-counter products. Many manufacturers are shifting their products from Rx (prescription) to OTC. In its 2019 annual report, Bayer AG declared it would convert some of its prescriptive medications suitable for self-care to OTC as part of its strategy. This strategy is expected to increase the availability of OTC medications for a variety of illnesses in developing and developed countries. Rx-to-OTC is a feasible and enticing alternative for organizations seeking a life cycle extension strategy, enabling consumers to take control of their health. Transitioning to an OTC model may assist in maintaining target revenue and increasing a product's lifetime value. Furthermore, organizations with pharmaceutical and consumer health sections can readily implement the Rx-to-OTC approach. Moreover, Rx-to-OTC conversions offer significant benefits to patients, retailers, and manufacturers. Patients like the unique benefits of OTC drugs, such as lower costs and the opportunity to make treatment decisions without the involvement of doctors or insurers. Retailers gain from having more selections on their shelves, especially if the product is well known. Furthermore, research has revealed that OTC medication products can save healthcare systems billions of dollars. As people spend more money on OTC products than on prescription drugs, there will be a tremendous need for OTC products in the future years, thereby driving the SAM market growth.

 

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the SAM dermatology OTC medications market. The SAM dermatology OTC medications market is expected to grow at a good CAGR during the forecast period. 

 

SAM Dermatology OTC Medications Market Revenue and Forecast to 2028 (US$ Million)    

SAM Dermatology OTC Medications Market Revenue and Forecast to 2028 (US$ Million)    

Get more information on this report :


SAM Dermatology OTC Medications Market Segmentation           

 

The SAM dermatology OTC medications market is segmented based on product type, route of administration, indication, distribution channel, and country. Based on product type, the market is segmented into tablets and capsules, gels, creams and ointments, and others. The creams and ointments segment dominated the market in 2020; however, the tablets and capsules segment is expected to be the fastest growing segment during the forecast period. Based on route of administration, the market is segmented into topical and oral. The topical segment dominated the market in 2020; however, oral segment is expected to be a faster growing segment during the forecast period. Based on indication, the market is segmented into dermatitis, acne, psoriasis, skin bleaching, fungal disease, warts, and others. The acne segment dominated the market in 2020 and is expected to be the fastest growing segment during the forecast period. The dermatitis segment is further classified into atopic dermatitis, contact dermatitis, and others. The acne segment is further segmented into non-inflammatory acne and inflammatory acne. The psoriasis segment is further segmented into plaque psoriasis, guttate psoriasis, and others. The fungal disease is further segmented into athlete's foot, ringworm, fungal nail infections, and others. Moreover, the warts segment is further segmented into common warts, flat warts, and others. Based on distribution channel, the market is segmented into online distribution and offline distribution. The offline distribution segment dominated the market in 2020 and online distribution segment is expected to be a faster growing segment during the forecast period. The offline distribution is further segmented into retail and hospital pharmacies and super and hypermarkets. Based on country, the market is segmented into Brazil, Argentina, and the rest of SAM.         

 

Bausch Health Companies Inc.; Bayer AG; Dr. Reddy's Laboratories; Galderma; GlaxoSmithKline plc.; Johnson and Johnson Services, Inc.; LEO Pharma A/S; Perrigo Company plc; and Viatris Inc. are among the leading companies in the SAM dermatology OTC medications market.

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        SAM Dermatology OTC Medications Market – By Product Type

1.3.2        SAM Dermatology OTC Medications Market – By Route of Administration

1.3.3        SAM Dermatology OTC Medications Market – By Indication

1.3.4        SAM Dermatology OTC Medications Market – By Distribution Channel

1.3.5        SAM Dermatology OTC Medications Market – By Country

2.           Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           SAM Dermatology OTC Medications Market – Market Landscape

4.1         Overview

4.2         SAM PEST Analysis

4.3         Experts Opinion

5.           SAM Dermatology OTC Medications Market – Key Market Dynamics

5.1         Key Market Drivers

5.1.1        High Prevalence of Skin Problems

5.1.2        Rising Income of Middle-Class Population

5.2         Market Restraints

5.2.1        Inappropriate Use of OTC Medications

5.3         Market Opportunities

5.3.1        Growing OTC Market

5.4         Future Trends

5.4.1        Transition from Rx to OTC

5.5         Impact Analysis of Drivers and Restraints

6.           Dermatology OTC Medications Market– SAM Analysis

6.1         SAM Dermatology OTC Medications Market Revenue Forecast and Analysis

7.           SAM Dermatology OTC Medications Market Analysis – By Product Type

7.1         Overview

7.2         SAM Dermatology OTC Medications Market Share by Product Type, 2021 & 2028 (%)

7.3         Tablets and Capsules

7.3.1        Overview

7.3.2        Tablets and Capsules Market Revenue and Forecast to 2028 (US$ million)

7.4         Gels

7.4.1        Overview

7.4.2        Gels Market Revenue and Forecast to 2028 (US$ million)

7.5         Creams and Ointments

7.5.1        Overview

7.5.2        Creams and Ointments Market Revenue and Forecast to 2028 (US$ million)

7.6         Others

7.6.1        Overview

7.6.2        Others Market Revenue and Forecast to 2028 (US$ million)

8.           SAM Dermatology OTC medications Market Analysis – By Route of Administration

8.1         Overview

8.2         SAM Dermatology OTC Medications Market Share, by Route of Administration, 2021 and 2028 (%)

8.3         Topical

8.3.1        Overview

8.3.2        Topical: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

8.4         Oral

8.4.1        Overview

8.4.2        Oral: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.           SAM Dermatology OTC Medications Market Analysis – By Indication

9.1         Overview

9.2         SAM Dermatology OTC Medications Market Share, by Indication, 2021 and 2028 (%)

9.3         Dermatitis

9.3.1        Overview

9.3.2        Dermatitis: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.3.3        Atopic Dermatitis

9.3.3.1          Overview

9.3.3.2          Atopic Dermatitis: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.3.4        Contact Dermatitis

9.3.4.1          Overview

9.3.4.2          Contact Dermatitis: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.3.5        Others

9.3.5.1          Overview

9.3.5.2          Others: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.4         Acne

9.4.1        Overview

9.4.2        Acne: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.4.3        Non-Inflammatory Acne

9.4.3.1          Overview

9.4.3.2          Non-Inflammatory Acne: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.4.4        Inflammatory Acne

9.4.4.1          Overview

9.4.4.2          Inflammatory Acne: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.5         Psoriasis

9.5.1        Overview

9.5.2        Psoriasis: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.5.3        Plaque Psoriasis

9.5.3.1          Overview

9.5.3.2          Plaque Psoriasis: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.5.4        Guttate Psoriasis

9.5.4.1          Overview

9.5.4.2          Guttate Psoriasis: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.5.5        Others

9.5.5.1          Overview

9.5.5.2          Others: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.6         Skin Bleaching

9.6.1        Overview

9.6.2        Skin Bleaching: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.7         Fungal Disease

9.7.1        Overview

9.7.2        Fungal Disease: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.7.3        Athlete's Foot

9.7.3.1          Overview

9.7.3.2          Athlete's Foot: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.7.4        Ringworm

9.7.4.1          Overview

9.7.4.2          Ringworm: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.7.5        Fungal Nail Infections

9.7.5.1          Overview

9.7.5.2          Fungal Nail Infections: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.7.6        Others

9.7.6.1          Overview

9.7.6.2          Others: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.8         Warts

9.8.1        Overview

9.8.2        Warts: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.8.3        Common Warts

9.8.3.1          Overview

9.8.3.2          Common Warts: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.8.4        Flat Warts

9.8.4.1          Overview

9.8.4.2          Flat Warts: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.8.5        Others

9.8.5.1          Overview

9.8.5.2          Others: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.9         Others

9.9.1        Overview

9.9.2        Others: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

10.        SAM Dermatology OTC medications Market Analysis – By Distribution Channel

10.1      Overview

10.2      SAM Dermatology OTC Medications Market Share, by Distribution Channel, 2021 and 2028 (%)

10.3      Online Distribution

10.3.1     Overview

10.3.2     Online Distribution: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

10.4      Offline Distribution

10.4.1     Overview

10.4.2     Offline Distribution: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

10.4.3     Retail and Hospital Pharmacies

10.4.3.1       Overview

10.4.3.2       Retail and Hospital Pharmacies: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

10.4.4     Super and Hyper Markets

10.4.4.1       Overview

10.4.4.2       Super and Hyper Markets: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

11.        SAM Dermatology OTC Medications Market Revenue and Forecasts to 2028 – Country Analysis

11.1      SAM: Dermatology OTC Medications Market Revenue and Forecasts To 2028

11.1.1     Overview

11.1.3     SAM: Dermatology OTC Medications Market, by Country, 2021 & 2028 (%)

11.1.4     Brazil: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

11.1.4.1       Overview

11.1.4.2       Brazil: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

11.1.4.3       Brazil: Dermatology OTC Medications Market, by Product Type, 2019–2028 (USD Million)

11.1.4.4       Brazil: Dermatology OTC Medications Market, by Route of Administration, 2019–2028 (USD Million)

11.1.4.5       Brazil: Dermatology OTC Medications Market, by Indication, 2019–2028 (USD Million)

11.1.4.5.1       Brazil: Dermatology OTC Medications Market, by Dermatitis, 2019–2028 (USD Million)

11.1.4.5.2       Brazil: Dermatology OTC Medications Market, by Acne, 2019–2028 (USD Million)

11.1.4.5.3       Brazil: Dermatology OTC Medications Market, by Psoriasis, 2019–2028 (USD Million)

11.1.4.5.4       Brazil: Dermatology OTC Medications Market, by Fungal Disease, 2019–2028 (USD Million)

11.1.4.5.5       Brazil: Dermatology OTC Medications Market, by Warts, 2019–2028 (USD Million)

11.1.4.6       Brazil: Dermatology OTC Medications Market, by Distribution Channel, 2019–2028 (USD Million)

11.1.4.6.1       Brazil: Dermatology OTC Medications Market, by Offline Distribution, 2019–2028 (USD Million)

11.1.5     Argentina: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

11.1.5.1       Overview

11.1.5.2       Argentina: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

11.1.5.3       Argentina: Dermatology OTC Medications Market, by Product Type, 2019–2028 (USD Million)

11.1.5.4       Argentina: Dermatology OTC Medications Market, by Route of Administration, 2019–2028 (USD Million)

11.1.5.5       Argentina: Dermatology OTC Medications Market, by Indication, 2019–2028 (USD Million)

11.1.5.5.1       Argentina: Dermatology OTC Medications Market, by Dermatitis, 2019–2028 (USD Million)

11.1.5.5.2       Argentina: Dermatology OTC Medications Market, by Acne, 2019–2028 (USD Million)

11.1.5.5.3       Argentina: Dermatology OTC Medications Market, by Psoriasis, 2019–2028 (USD Million)

11.1.5.5.4       Argentina: Dermatology OTC Medications Market, by Fungal Disease, 2019–2028 (USD Million)

11.1.5.5.5       Argentina: Dermatology OTC Medications Market, by Warts, 2019–2028 (USD Million)

11.1.5.6       Argentina: Dermatology OTC Medications Market, by Distribution Channel, 2019–2028 (USD Million)

11.1.5.6.1       Argentina: Dermatology OTC Medications Market, by Offline Distribution, 2019–2028 (USD Million)

11.1.6     Rest of SAM: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

11.1.6.1       Overview

11.1.6.2       Rest of SAM: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

11.1.6.3       Rest of SAM: Dermatology OTC Medications Market, by Product Type, 2019–2028 (USD Million)

11.1.6.4       Rest of SAM: Dermatology OTC Medications Market, by Route of Administration, 2019–2028 (USD Million)

11.1.6.5       Rest of SAM: Dermatology OTC Medications Market, by Indication, 2019–2028 (USD Million)

11.1.6.5.1       Rest of SAM: Dermatology OTC Medications Market, by Dermatitis, 2019–2028 (USD Million)

11.1.6.5.2       Rest of SAM: Dermatology OTC Medications Market, by Acne, 2019–2028 (USD Million)

11.1.6.5.3       Rest of SAM: Dermatology OTC Medications Market, by Psoriasis, 2019–2028 (USD Million)

11.1.6.5.4       Rest of SAM: Dermatology OTC Medications Market, by Fungal Disease, 2019–2028 (USD Million)

11.1.6.5.5       Rest of SAM: Dermatology OTC Medications Market, by Warts, 2019–2028 (USD Million)

11.1.6.6       Rest of SAM: Dermatology OTC Medications Market, by Distribution Channel, 2019–2028 (USD Million)

11.1.6.6.1       Rest of SAM: Dermatology OTC Medications Market, by Offline Distribution, 2019–2028 (USD Million)

12.        Industry Landscape

12.1      Overview

12.2      Inorganic Growth Strategies

12.2.1     Overview

12.3      Organic Growth Strategies

12.3.1     Overview

13.        Company Profiles

13.1      Bausch Health Companies Inc.

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2      Perrigo Company plc

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3      Bayer AG

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4      Viatris Inc.

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5      Johnson and Johnson Services, Inc.

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6      LEO Pharma A/S

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

13.7      GlaxoSmithKline plc.

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Products and Services

13.7.4     Financial Overview

13.7.5     SWOT Analysis

13.7.6     Key Developments

13.8      Galderma

13.8.1     Key Facts

13.8.2     Business Description

13.8.3     Products and Services

13.8.4     Financial Overview

13.8.5     SWOT Analysis

13.8.6     Key Developments

13.9      Dr. Reddy's Laboratories

13.9.1     Key Facts

13.9.2     Business Description

13.9.3     Products and Services

13.9.4     Financial Overview

13.9.5     SWOT Analysis

13.9.6     Key Developments

14.        Appendix

14.1      Glossary of Terms

LIST OF TABLES

Table 1.             SAM Dermatology OTC Medications Market, Revenue and Forecast, 2019–2028 (US$ Mn)

Table 2.             Brazil: Dermatology OTC Medications Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 3.             Brazil: Dermatology OTC Medications Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 4.             Brazil: Dermatology OTC Medications Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 5.             Brazil: Dermatology OTC Medications Market, by Dermatitis – Revenue and Forecast to 2028 (USD Million)

Table 6.             Brazil: Dermatology OTC Medications Market, by Acne – Revenue and Forecast to 2028 (USD Million)

Table 7.             Brazil: Dermatology OTC Medications Market, by Psoriasis – Revenue and Forecast to 2028 (USD Million)

Table 8.             Brazil: Dermatology OTC Medications Market, by Fungal Disease – Revenue and Forecast to 2028 (USD Million)

Table 9.             Brazil: Dermatology OTC Medications Market, by Warts – Revenue and Forecast to 2028 (USD Million)

Table 10.          Brazil: Dermatology OTC Medications Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 11.          Brazil: Dermatology OTC Medications Market, by Offline Distribution – Revenue and Forecast to 2028 (USD Million)

Table 12.          Argentina: Dermatology OTC Medications Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 13.          Argentina: Dermatology OTC Medications Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 14.          Argentina: Dermatology OTC Medications Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 15.          Argentina: Dermatology OTC Medications Market, by Dermatitis – Revenue and Forecast to 2028 (USD Million)

Table 16.          Argentina: Dermatology OTC Medications Market, by Acne – Revenue and Forecast to 2028 (USD Million)

Table 17.          Argentina: Dermatology OTC Medications Market, by Psoriasis – Revenue and Forecast to 2028 (USD Million)

Table 18.          Argentina: Dermatology OTC Medications Market, by Fungal Disease – Revenue and Forecast to 2028 (USD Million)

Table 19.          Argentina: Dermatology OTC Medications Market, by Warts – Revenue and Forecast to 2028 (USD Million)

Table 20.          Argentina: Dermatology OTC Medications Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 21.          Argentina: Dermatology OTC Medications Market, by Offline Distribution – Revenue and Forecast to 2028 (USD Million)

Table 22.          Rest of SAM: Dermatology OTC Medications Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 23.          Rest of SAM: Dermatology OTC Medications Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 24.          Rest of SAM: Dermatology OTC Medications Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 25.          Rest of SAM: Dermatology OTC Medications Market, by Dermatitis – Revenue and Forecast to 2028 (USD Million)

Table 26.          Rest of SAM: Dermatology OTC Medications Market, by Acne – Revenue and Forecast to 2028 (USD Million)

Table 27.          Rest of SAM: Dermatology OTC Medications Market, by Psoriasis – Revenue and Forecast to 2028 (USD Million)

Table 28.          Rest of SAM: Dermatology OTC Medications Market, by Fungal Disease – Revenue and Forecast to 2028 (USD Million)

Table 29.          Rest of SAM: Dermatology OTC Medications Market, by Warts – Revenue and Forecast to 2028 (USD Million)

Table 30.          Rest of SAM: Dermatology OTC Medications Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 31.          Rest of SAM: Dermatology OTC Medications Market, by Offline Distribution – Revenue and Forecast to 2028 (USD Million)

Table 32.          Recent Inorganic Growth Strategies

Table 33.          Recent Organic Growth Strategies

Table 34.          Glossary of Terms

 

 

LIST OF FIGURES

Figure 1.           SAM Dermatology OTC Medications Market Segmentation

Figure 2.           SAM Dermatology OTC Medications Market, By Country

Figure 3.           SAM Dermatology OTC Medications Market Overview

Figure 4.           Creams and Ointments Segment Held the Largest Share of the Market in 2021

Figure 5.           Brazil held the Largest Share of the Market in 2021

Figure 6.           SAM: PEST Analysis

Figure 7.           Experts Opinion

Figure 8.           SAM Dermatology OTC Medications Market Impact Analysis of Drivers and Restraints

Figure 9.           SAM Dermatology OTC Medications Market – By Forecast and Analysis

Figure 10.        SAM Dermatology OTC Medications Market Share by Product Type, 2021 & 2028 (%)

Figure 11.        SAM Tablets and Capsules Market Revenue and Forecasts to 2028 (US$ million)

Figure 12.        SAM Gels Market Revenue and Forecasts to 2028 (US$ million)

Figure 13.        SAM Creams and Ointments Market Revenue and Forecasts to 2028 (US$ million)

Figure 14.        SAM Others Market Revenue and Forecasts to 2028 (US$ million)

Figure 15.        SAM Dermatology OTC Medications market Share, by Route of Administration, 2021 and 2028 (%)

Figure 16.        SAM Topical: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 17.        SAM Oral: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 18.        SAM Dermatology OTC Medications Market Share, by Indication, 2021 and 2028 (%)

Figure 19.        SAM Dermatitis: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 20.        SAM Atopic Dermatitis: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 21.        SAM Contact Dermatitis: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 22.        SAM Others: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 23.        SAM Acne: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 24.        SAM Non-Inflammatory Acne: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 25.        SAM Inflammatory Acne: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 26.        SAM Psoriasis: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 27.        SAM Plaque Psoriasis: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 28.        SAM Guttate Psoriasis: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 29.        SAM Others: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 30.        SAM Skin Bleaching: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 31.        SAM Fungal Disease: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 32.        SAM Athlete's Foot: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 33.        SAM Ringworm: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 34.        SAM Fungal Nail Infections: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 35.        SAM Others: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 36.        SAM Warts: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 37.        SAM Common Warts: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 38.        SAM Flat Warts: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 39.        SAM Others: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 40.        SAM Others: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 41.        SAM Dermatology OTC Medications market Share, by Distribution Channel, 2021 and 2028 (%)

Figure 42.        SAM Online Distribution: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 43.        SAM Offline Distribution: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 44.        SAM Retail and Hospital Pharmacies: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 45.        SAM Super and Hyper Markets: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 46.        SAM: Dermatology OTC Medications Market, by Key Country – Revenue (2021) (USD Million)

Figure 47.        SAM: Dermatology OTC Medications Market, by Country, 2021 & 2028 (%)

Figure 48.        Brazil: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

Figure 49.        Argentina: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

Figure 50.        Rest of SAM: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

  1. Bausch Health Companies Inc.
  2. Bayer AG  
  3. Dr. Reddy's Laboratories
  4. Galderma
  5. GlaxoSmithKline plc.
  6. Johnson and Johnson Services, Inc.
  7. LEO Pharma A/S       
  8. Perrigo Company plc
  9. Viatris Inc.  
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the SAM dermatology OTC medications market.           
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the SAM dermatology OTC medications market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth SAM market trends and outlook coupled with the factors driving the dermatology OTC medications market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution  
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3000
$2400
Site License
$4000
$3200
Enterprise License
$5000
$4000